Biology
Biology News
Natural compound stops retinopathy
| 7/2/2009 | OKLAHOMA CITY Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States. The research appears online this month in the journal Diabetes , a publication of the American Diabet... [Comments] |  |
UT multimedia program increases middle school interest in science
| 7/2/2009 | Middle school students who were part of a unique science learning program developed by The University of Texas School of Public Health showed significant increases in interest and achievement scores compared to other students, a recent study found. Results from the study are published in the June issue of the Association of American Medical Colleges' Academic Medicine . The program,... [Comments] |
Ben-Gurion U. researchers reveal connection between cancer and human evolution
| 7/2/2009 | BEER-SHEVA, ISRAEL, July 2, 2009 Researchers at Ben-Gurion University of the Negev (BGU) have discovered that gene mutations that once helped humans survive may increase the possibility for diseases, including cancer. The findings were recently the cover story in the journal Genome Research . The team of researchers from BGU's National Institute for Biotechnology in the Negev (NIBN) set o... [Comments] |
Pacific Northwest forests could store more carbon, help address greenhouse issues
| 7/2/2009 | CORVALLIS, Ore. The forests of the Pacific Northwest hold significant potential to increase carbon storage and help mitigate greenhouse gas emissions in coming years, a recent study concludes, if they are managed primarily for that purpose through timber harvest reductions and increased rotation ages. In the complete absence of stand-replacing disturbances via fire or timber harvest for... [Comments] |
Brain malformations significantly associated with preterm birth, Wake Forest research shows
| 7/2/2009 | WINSTON-SALEM, N.C. New research out of Wake Forest University School of Medicine provides for the first time a solid scientific answer for the long-standing question of whether there is an association between preterm birth and brain malformations. In a study of more than 1,000 preterm infant autopsies, researchers found that there is a strong association between congenital brain defects... [Comments] |
Evolution: Crabs go deep to avoid hot water
| 7/2/2009 | Researchers from the National Oceanography Centre, Southampton, have drawn together 200 years' worth of oceanographic knowledge to investigate the distribution of a notorious deep-sea giant the king crab. The results, published this week in the Journal of Biogeography , reveal temperature as a driving force behind the speciation and radiation of a major seafloor predator; globally, and over... [Comments] |
| 7/2/2009 | The Archaea are single-celled organisms and a domain unto themselves, quite apart from the so called eukaryotes, being bacteria and higher organisms. Many species live under extreme conditions, and carry out unique biochemical processes shared neither with bacteria nor with eukaryotes. Methanogenic archaeans, for example, can produce methane gas out of carbon dioxide and hydrogen. The underlyi... [Comments] |
| 7/2/2009 | Bremerhaven, July 2nd 2009. A new measurement system for the detection of whales is used for the first time on board of the research vessel Polarstern. Whales are usually difficult to spot. On the one hand, they spend the greater part of their life under water. On the other hand, only a small... [Comments] |  |
Biology Products
Mouse Anti-Snail, a.a. 150-39 Antibody, Unconjugated from CHEMICON
Description:Snail, a.a. 150-39...Company:CHEMICON
Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, Unconjugated, Clone LO-MM-3 from Cell Sciences
Description:Anti-Mouse IgM Heavy Chain, Clone LO-MM-3, Monoclonal Antibody...Company:Cell Sciences
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...Company:ProSci, Inc
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Biology Technology
ACT Announces Partnership With Gilead Sciences Inc.
| 7/2/2009 | SUNNYVALE, Calif., July 2 Advanced Chemical Transport, one of the leading environmental companies in California, has announced a multi-year partnership with Gilead Sciences Inc., North America's third largest Bio-Med company. ACT will provide Environmental services - including hazardous Materials disposal, vacuum truck services, spill response, site specific services... [Comments] |
| 7/2/2009 | PHOENIX, July 2 As many as five to ten million males in the U.S. struggle quietly with an eating disorder because they're ashamed to admit they have the illness, reports Remuda Ranch Programs for Eating and Anxiety Disorders . Healthcare professionals, family members and close friends often are unaware of the high-risk behaviors in males that may signify an eating disord... [Comments] |
| 7/2/2009 | LUMBY, BC, July 2 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the engagement of Koeppel Direct to manage their direct response media buying. Lorie Campbell-Farley, President/COO of avVaa World Health Care i... [Comments] |
| 7/2/2009 | EAST SETAUKET, N.Y., July 2 Lixte Biotechnology Holdings (OTC Bulletin Board: LIXT) announced today that investigators of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI), National Institutes of Health and Lixte reported that its novel compound, LB-1.2, enhances the effectiveness of two standard chemotherapy... [Comments] |
| 7/2/2009 | CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with paclitaxel/carboplatin for patients with advanced cancers. The principal investigators for the trial are Dr. Kevin Harrington of The Institute of Cancer Research, L... [Comments] |
(Date:7/2/2009)...f proteins that are highly effective at killing ba...new types of antibiotics. , Researchers from the...3.3m from the Biotechnology and Biological Science...y of proteins known as colicins force their way in... team, led by Professor Colin Kleanthous, from the...
(Date:7/1/2009)...ohnson today announced that Axel Ullrich, Ph.D., d...the Max Planck Institute of Biochemistry in German...apies including Herceptin (trastuzumab) , is the w...dical Research. An independent committee of world...September 8 will receive a $100,000 prize during a...
(Date:7/1/2009)...onsible for repairing DNA strands damaged by oxida...dditional evidence that such stress contributes to...of a recent study* in DNA Repair by researchers ...ogy (NIST), Oregon Health and Science University (...ne (NYUSM). , Although all cells need oxygen to ...
(Date:7/1/2009)...he first time, scientists have shown that chromoso...IVF embryos, even those produced by young, fertile...e Centre for Human Genetics and the University Fer...e 25th annual conference of the European Society o...ay July 1), that the surprising finding meant that...
Breaking Biology News(10 mins):Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Genetically engineered mice yield clues to 'knocking out' cancer 2Chromosomal problems affect nearly all human embryos 2Chromosomal problems affect nearly all human embryos 3MHA Announces 3A Managed Health Care Associates Inc 28MHA 29 Expands Board of Directors 9322 1MHA Announces 3A Managed Health Care Associates Inc 28MHA 29 Expands Board of Directors 9322 2MHA Announces 3A Managed Health Care Associates Inc 28MHA 29 Expands Board of Directors 9322 3Worse Than Love Canal A Town Poisoned by Corporate Greed 9319 1Worse Than Love Canal A Town Poisoned by Corporate Greed 9319 2Novo Nordisk Appoints Alan C Moses as Chief Medical Officer Worldwide 2526 1Novo Nordisk Appoints Alan C Moses as Chief Medical Officer Worldwide 2526 2Clarient to Commercialize Novel Breast Cancer Profile 2523 1Clarient to Commercialize Novel Breast Cancer Profile 2523 2Clarient to Commercialize Novel Breast Cancer Profile 2523 3Clarient to Commercialize Novel Breast Cancer Profile 2523 4Clarient to Commercialize Novel Breast Cancer Profile 2523 5...e early development of new neurons in specific bra...the adult brain, new research shows. How these ne...s may explain how they can affect learning and mem...Fred Gage, PhD, of the Salk Institute, found that ... a brain area called the dentate gyrus, and that m...
... not as well known as other, more widely used subj...the fruit fly, nematode or mouse. But University o...r Phillip Newmark thinks it should be. As it turns...n ideal subject for the study of germ cells, precu...g species. , The planarian Newmark studies, Schm...
...on neurodevelopmental disorder characterized by se...ral functions. It is thought that genetic make-up ...enes have been associated with the development of ...s been identified to be associated with susceptibi...ad been directly implicated in the disorder until ...
...hy we shed tears. But exactly what our tears are m...ew study sheds some light on the complex design of... tear film, which is made up of three distinct, mi...e normally think of as tears when we cry ?is sandw...of fatty, oily substances collectively called meib...
Other Biology News:Experience affects new neuron survival in adult brain; study sheds light on learning, memory 2Study of planarians offers insight into germ cell development 2Tears reveal some of their deepest secrets to researchers 2Tears reveal some of their deepest secrets to researchers 3IgD Chain C (AMS 9.1)
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays.
quantitation of phosphatase activity, evaluation of hits and leads from HTS
...earch Registered OLAW Assured AAALAC Accredited Al...tified Technicians Documentation GLP Process for...cus CRP is your one stop shopping point for all y...e project consultation, free peptide sequence reco...
Biology Products:(Date:7/1/2009)...h duration of efficacy from two hours up to 14 hou... HOLLYWOOD, Fla., July 1 ...l specialty biopharmaceutical company, today annou...NSE(R) (lisdexamfetamine dimesylate) CII demonstra...tration during a simulated workplace environment s...
(Date:7/1/2009)...-- Encorium Group, Inc. (Nasdaq: ENCO ) , a ful...tion (CRO) that provides design, development, and ...tient registries to many of the world,s leading ph...o the expected timeframe surrounding its previousl...international contract research organization liste...
(Date:7/1/2009)... NeoStem, Inc. (NYSE Amex: NBS ) announced today... $4 million from institutional and private investo...vate placement from three Asia-based investors ann...obtained by NeoStem in the past two and half month... Suzhou Erye Pharmaceuticals Company, Ltd. have in...
(Date:7/1/2009)...Newswire/ -- Human Genome Sciences, Inc. (Nasdaq: ...op-line results available on Monday, July 20, from...al trials of BENLYSTA(TM) (belimumab, formerly Lym...). , , (Logo: http://www.newscom.com/cgi-b...ment will host a conference call to discuss the re...
Breaking Biology Technology:Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 2Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 3Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 4Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 6Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 7Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 8Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 2Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 3Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 4NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 2NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 3Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2[0] Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment[0] Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business[0] NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State[0] Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
...nies has changed radically since 2001. This realit...s, as they analyze past trends, to figure out how ... start with the Initial Public Offering (IPO) mark... (those that had invested in prior financing round...ods of 6 to 10 months when an IPO window would be ...
...growing belief that whenever a state company is ac...ership inevitably harms the state,s economy. But t...tion Networks Corp . by Illinois-based CDW Corp ....h states, according to those closest to the deal. ...ives in both companies and an attorney familiar wi...
...iring patents, generic drugs, and increasing costs...utical companies are increasingly turning to innov...c scientific development efforts and produce new b...he Wisconsin Biotechnology and Medical Device Ass...from Astellas Pharma, Inc. , Abbot Laboratories ...
...ve year, the City of Madison received recognitio...ssible municipalities in the country. , ,In its 2...nment , a national research and advisory institute...tate and local government, honored the city as the...ulation category. Madison tied with the City of A...
Other Biology Technology:Financing life science: The ongoing saga 2Financing life science: The ongoing saga 3Financing life science: The ongoing saga 4Financing life science: The ongoing saga 5Financing life science: The ongoing saga 6Anatomy of a deal: CDW and Berbee 2Anatomy of a deal: CDW and Berbee 3Anatomy of a deal: CDW and Berbee 4Big pharma seeks Wisconsin biotech partnerships 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |